WASP/Wiskott-Aldrich syndrome protein Rabbit Monoclonal Antibody

WASP/Wiskott-Aldrich syndrome protein Rabbit Monoclonal Antibody

Cat: AMRe87336
Size:50μL Price:$168
Size:100μL Price:$300
Application:WB,ICC/IF,FC

Reactivity:Human
Conjugate:Unconjugated
Optional conjugates: Biotin, FITC (free of charge).
See other 26 conjugates.

Gene Name:WASP/Wiskott-Aldrich syndrome protein
Category: Recombinant Monoclonal Antibody Tags: , , , , ,

Summary

Production Name

WASP/Wiskott-Aldrich syndrome protein Rabbit Monoclonal Antibody

Description

Recombinant rabbit monoclonal antibody

Host

Rabbit

Application

WB,ICC/IF,FC

Reactivity

Human

 

Performance

Conjugation

Unconjugated

Modification

Unmodified

Isotype

IgG

Clonality

Monoclonal

Form

Liquid

Storage

Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.

Buffer

Supplied in 50mM Tris-Glycine(pH 7.4), 0.15M NaCl, 40% Glycerol, 0.01% sodium azide and 0.05% protective protein. Stable for 12 months from date of receipt.

Purification

Affinity Purification

 

Immunogen

Gene Name

WASP/Wiskott-Aldrich syndrome protein

Alternative Names

THC; IMD2; SCNX; THC1; WASP; WASPA

Gene ID

7454

SwissProt ID

P42768

 

Application

Dilution Ratio

WB 1:2000-1:20000,ICC/IF 1:20-1:50,FC 1:20-1:50

Molecular Weight

Calculated MW:53 kDa; Observed MW:60 kDa

 

Background

The Wiskott-Aldrich syndrome (WAS) family of proteins share similar domain structure, and are involved in transduction of signals from receptors on the cell surface to the actin cytoskeleton. The presence of a number of different motifs suggests that they are regulated by a number of different stimuli, and interact with multiple proteins. Recent studies have demonstrated that these proteins, directly or indirectly, associate with the small GTPase, Cdc42, known to regulate formation of actin filaments, and the cytoskeletal organizing complex, Arp2/3. Wiskott-Aldrich syndrome is a rare, inherited, X-linked, recessive disease characterized by immune dysregulation and microthrombocytopenia, and is caused by mutations in the WAS gene. The WAS gene product is a cytoplasmic protein, expressed exclusively in hematopoietic cells, which show signalling and cytoskeletal abnormalities in WAS patients. A transcript variant arising as a result of alternative promoter usage, and containing a different 5' UTR sequence, has been described, however, its full-length nature is not known. [provided by RefSeq, Jul 2008]

 

Research Area

   💬 WhatsApp